IRIS
DI NISIO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.023
EU - Europa 3.385
AS - Asia 1.945
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
AF - Africa 8
SA - Sud America 5
Totale 10.388
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.007
IE - Irlanda 776
CN - Cina 739
SG - Singapore 636
UA - Ucraina 621
SE - Svezia 525
IT - Italia 417
TR - Turchia 411
GB - Regno Unito 262
DE - Germania 216
FR - Francia 168
FI - Finlandia 153
RU - Federazione Russa 138
IN - India 61
VN - Vietnam 31
BE - Belgio 25
TW - Taiwan 22
NL - Olanda 20
AT - Austria 17
ES - Italia 14
CA - Canada 13
CZ - Repubblica Ceca 13
EU - Europa 12
AU - Australia 9
IR - Iran 7
HK - Hong Kong 6
TH - Thailandia 6
ID - Indonesia 5
IL - Israele 5
KR - Corea 5
JP - Giappone 4
HR - Croazia 3
KE - Kenya 3
NO - Norvegia 3
RO - Romania 3
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
MA - Marocco 2
MY - Malesia 2
SR - Suriname 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BR - Brasile 1
CR - Costa Rica 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
Totale 10.388
Salva come PNG Salva come JPEG
Città #
Chandler 1.002
Jacksonville 873
Dublin 765
Singapore 541
Princeton 397
Izmir 275
Ashburn 224
Nanjing 219
Altamura 186
Southend 179
Wilmington 170
Santa Clara 142
Cambridge 139
Dearborn 135
Beijing 123
Boardman 90
Ann Arbor 83
Nanchang 72
Woodbridge 68
Chieti 61
Houston 58
Los Angeles 55
Helsinki 49
Hebei 46
Kunming 44
Shenyang 36
Tianjin 36
Washington 36
Jiaxing 35
Dong Ket 31
Seattle 29
Changsha 25
Brussels 23
Norwalk 22
New York 21
Hangzhou 17
Vienna 17
Fairfield 14
Falls Church 13
Leawood 13
Munich 13
Pune 13
Grevenbroich 12
Olomouc 11
Taipei 11
Guangzhou 10
Hefei 10
Edinburgh 9
San Mateo 9
Changchun 8
Jinan 8
Madrid 8
Romola 8
Ardabil 7
Hanover 7
Orange 7
Sydney 7
Amsterdam 6
Augusta 6
Bangkok 6
Mountain View 6
Suresnes 6
Teramo 6
Cheyenne 5
Frankfurt am Main 5
Redwood City 5
Rochester 5
Rome 5
Saint Louis 5
Auburn Hills 4
Clifton 4
Des Moines 4
Florence 4
Hong Kong 4
Lanzhou 4
Monmouth Junction 4
Moscow 4
Mumbai 4
New Taipei 4
Ningbo 4
Paris 4
Pescara 4
Plymouth 4
San Antonio 4
Seveso 4
Shanghai 4
Stockholm 4
Tappahannock 4
Vasto 4
Zhengzhou 4
Alba Adriatica 3
Andover 3
Bucharest 3
Gangbuk-gu 3
Kocaeli 3
London 3
Marseille 3
Mcallen 3
Milan 3
Montenero Di Bisaccia 3
Totale 6.702
Salva come PNG Salva come JPEG
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 194
Supportive management strategies for disseminated intravascular coagulation: An international consensus 131
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 113
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 108
Treatment of Lower Extremity Superficial Thrombophlebitis 98
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 95
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 88
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 85
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 85
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 85
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 84
Circulating leptin is associated with oxidized LDL in postmenopausal women. 83
The hematocrit and platelet target in polycytemia vera 79
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 78
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 77
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 77
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 76
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 76
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 76
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 76
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 76
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 75
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 75
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 74
Rivaroxaban for cancer-associated cardiac thrombosis 74
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 73
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 73
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 73
Improving the diagnostic management of upper extremity deep vein thrombosis 72
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 72
Non-O blood group and outcomes of in vitro fertilization 71
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 70
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 69
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 69
Antithrombotic therapy and cancer 69
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 68
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 67
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 67
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 67
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 67
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 67
Transforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 66
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 66
D-Dimer test in cancer patients with suspected acute pulmonary embolism 66
Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma. 65
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and symptomatic pulmonary embolism: a systematic review 65
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 65
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 65
Effects of body composition on the procoagulant imbalance in obese patients 65
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 64
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 64
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 64
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 64
The SISET incorrectly cited the JAAM DIC scoring system 63
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 63
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 63
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 63
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving high dose chemotherapy for hematological malignancies, a randomized placebo controlled study 62
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 62
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 62
Treatment for superficial infusion thrombophlebitis of the upper extremity. 61
Cannabinoids for medical use: A systematic review and meta-analysis 61
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 61
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 60
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. 60
Deep vein thrombosis and pulmonary embolism 60
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 60
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 60
Pravastatin-dependent TGF-β1 effect on scavenger receptor class A expression in THP-1 human macrophages 60
Decision analysis for cancer screening in idiopathic venous thromboembolism 59
Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: A systematic review 59
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 59
Diagnosis and treatment of incidental venous thromboembolism in cancer patients: Guidance from the SSC of the ISTH 59
Cell-derived microvesicles and cancer 58
Plasma cytokines and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular-weight heparin administration 58
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 58
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH 58
Edoxaban for the treatment of cancer-associated venous thromboembolism 58
Splanchnic vein thrombosis: Current perspectives 58
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 58
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants 58
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 58
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 57
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 57
Cancer-associated unsuspected pulmonary embolism 57
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 57
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 57
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 57
Proximal and isolated distal deep vein thrombosis and Wells score accuracy in hospitalized patients 57
Low molecular-weight heparins improve the survival of cancer patients? 56
Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer 56
Treatment for superficial thrombophlebitis of the leg 56
Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study 56
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 56
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 56
Prevention of venous thromboembolism in hospitalized medical cancer patients: Guidance from the SSC of the ISTH 56
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome 56
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment 56
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 56
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 56
Totale 6.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.216
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.082 0 0 0 24 170 88 241 139 43 157 198 22
2020/2021990 129 20 280 27 73 230 10 9 13 70 50 79
2021/2022765 10 11 9 117 36 27 31 66 53 22 108 275
2022/20232.969 251 390 134 309 328 590 158 227 384 43 95 60
2023/20241.290 98 45 141 48 106 375 255 49 27 39 5 102
2024/20251.254 203 626 409 16 0 0 0 0 0 0 0 0
Totale 11.086